ZGNX News and Press, Zogenix Inc. From 04/15/19

SAN FRANCISCO , April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc. (NASDAQ: ZGNX) to the firm's investigation of possible Federal securities law violations.  If you purchased or otherwise acquired Zogenix securities between January...

SAN DIEGO , April 13, 2019 /PRNewswire/ -- Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq. , is investigating potential claims against Zogenix, Inc. ("Zogenix") (NASDAQ: ZGNX) for violations of federal...

In business and in particular drug development, rarely do things go as planned. Zogenix ( ZGNX ) is a pharmaceutical company developing therapies for people living with serious and life-threatening rare central nervous system (CNS') conditions. Zogenix's lead product candidate Fintepla is low-...

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Zogenix, Inc. investors (“Zogenix” or the “Company”) (NASDAQ:  ZGNX ) concerning the Company and its officers’ possible violations of federal securities ...

BOSTON, April 10, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether Zogenix, Inc. (“Zogenix” or the “Company”) (NASDAQ: ZGNX) and certain of its office...

Gainers: ATA (NASDAQ: ATAI ) +97% . Provention Bio (NASDAQ: PRVB ) +29% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +24% . Chimerix (NASDAQ: CMRX ) +22% . FARO Technologies (NASDAQ: FARO ) +17% . Soliton (NASDAQ: SOLY ) +15% . GEE Group (NYSEMKT: JOB ) +14% . Geron (NASDAQ: GERN ) ...

Vaxart (NASDAQ: VXRT )  -37%  on pricing stock offering. More news on: Vaxart, Inc., Zogenix, Inc., Zosano Pharma Corporation, Stocks on the move, Read more ...

Ionis Pharmaceuticals (NASDAQ: IONS ) initiated with Neutral rating at Cantor Fitzgerald citing Spinraza headwinds. More news on: Ionis Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Geron Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Gainers: PHAS   +31.6% . GWPH   +4.1% . RUHN   +2.9% . IGC   +1.9% . SENS   +1.9% . More news on: PhaseBio Pharmaceuticals, Inc., GW Pharmaceuticals plc, Hangzhou Ruhnn Holding Co.,Ltd, Stocks on the move, Read more ...

The FDA has issued a Refusal to File (RTF) letter to Zogenix (NASDAQ: ZGNX ) related to its marketing application seeking approval for FINTEPLA (fenfluramine hydrochloride) for the treatment of seizures associated with a rare and severe form of epilepsy called Dravet syndrome. More news ...